TWD 10.7
(-1.38%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | -33.65 Million | 60.82 Million | -10.43 Million | -2.48 Million | 4.09 Million |
Net Income | -19.84 Million | 24.42 Million | 18.25 Million | -49.68 Million | -11.96 Million |
Depreciation & Amortization | 12.52 Million | 11.86 Million | 12.29 Million | 16.39 Million | 19.57 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -3.92 Million | 29.16 Million | -39.51 Million | 22.44 Million | 20.73 Million |
Other non-cash items | -7.18 Million | -1.43 Million | 1.03 Million | -1.1 Million | -24.25 Million |
Investing Cash Flow | -107.64 Million | -17.92 Million | 9.94 Million | -90.59 Million | -11.19 Million |
Investments in PPE | -105.15 Million | -7.42 Million | -6.33 Million | -7.31 Million | -14.85 Million |
Acquisitions | 2.1 Million | - | - | - | - |
Investment purchases | -35.28 Million | -31.7 Million | 2.39 Million | -91.5 Million | - |
Sales/Maturities of investments | 8.7 Million | 13.64 Million | 8.21 Million | 2.53 Million | - |
Other Investing Activities | -2.49 Million | - | - | - | 3.66 Million |
Financing Cash Flow | 75.97 Million | -47 Million | 7 Million | 11 Million | 18 Million |
Debt repayment | -75.97 Million | -47 Million | -7 Million | -11 Million | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | 75.97 Million | - | - | - | 18 Million |
Accounts receivables | -10.76 Million | - | - | - | 23.14 Million |
Accounts payables | -420 Thousand | - | - | - | - |
Inventory | 7.56 Million | 14.6 Million | -30.23 Million | 12.43 Million | -14.85 Million |
Other working capital | -375 Thousand | - | - | - | 12.44 Million |
Cash at beginning of period | 81.16 Million | 85.26 Million | 78.74 Million | 160.82 Million | 149.92 Million |
Cash at end of period | 15.83 Million | 81.16 Million | 85.26 Million | 78.74 Million | 160.82 Million |
Capital Expenditure | -105.15 Million | -7.42 Million | -6.33 Million | -7.31 Million | -14.85 Million |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -65.33 Million | -4.1 Million | 6.51 Million | -82.07 Million | 10.9 Million |
Free Cash Flow | -138.81 Million | 53.39 Million | -16.76 Million | -9.79 Million | -10.75 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -9.55 Million | -5.98 Million | -19.25 Million | -19.84 Million | -4.73 Million | 13.92 Million |
Depreciation & Amortization | 4.91 Million | 4.13 Million | 3.91 Million | 12.52 Million | 3.01 Million | 2.84 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -19.4 Million | 24.86 Million | 7.85 Million | -3.92 Million | -32.42 Million | 49.32 Million |
Other non-cash items | -1.41 Million | -2.41 Million | -1.45 Million | -7.18 Million | -3.03 Million | -667 Thousand |
Investing Cash Flow | -17.99 Million | -6.92 Million | -31.53 Million | -107.64 Million | -49.76 Million | 9.24 Million |
Investments in PPE | -5.05 Million | -2.45 Million | -34.8 Million | -105.15 Million | -46.62 Million | -18.23 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -18.38 Million | -5.39 Million | 7.6 Million | -35.28 Million | -8.71 Million | 1.28 Million |
Sales/Maturities of investments | 2.7 Million | 918 Thousand | -4.34 Million | 8.7 Million | 4.61 Million | 5.16 Million |
Other Investing Activities | -12.94 Million | - | - | - | - | - |
Financing Cash Flow | 39.73 Million | -1.41 Million | 43.97 Million | 75.97 Million | 52 Million | -43.27 Million |
Debt repayment | -39.73 Million | -1.41 Million | -43.97 Million | -75.97 Million | -52 Million | -43.27 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 39.73 Million | - | - | - | - | - |
Accounts receivables | -7.63 Million | - | - | - | - | - |
Accounts payables | -1.29 Million | - | - | - | - | - |
Inventory | 2.76 Million | -3.63 Million | 3.55 Million | 7.56 Million | 3.47 Million | 2.57 Million |
Other working capital | -13.21 Million | - | - | - | - | - |
Cash at beginning of period | 29.36 Million | 15.83 Million | 8.42 Million | 81.16 Million | 42.2 Million | 32.96 Million |
Cash at end of period | 22.3 Million | 29.36 Million | 15.83 Million | 15.83 Million | 8.42 Million | 42.2 Million |
Capital Expenditure | -5.05 Million | -2.45 Million | -34.8 Million | -105.15 Million | -46.62 Million | -18.23 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -7.05 Million | 13.53 Million | 7.4 Million | -65.33 Million | -33.78 Million | 9.23 Million |
Free Cash Flow | -33.84 Million | 19.42 Million | -39.82 Million | -138.81 Million | -82.64 Million | 25.02 Million |
MEDXF
MKC-V
0244
SHANF
007070
002080